RedHill Biopharma Ltd.
RDHL
$1.64
-$0.09-5.20%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
10/22/2025
-
GuruFocus
10/22/2025
-
PR Newswire
10/20/2025
-
PR Newswire
10/20/2025
-
The Fly
10/20/2025
-
PR Newswire
10/17/2025
-
Ticker Report
10/9/2025
-
Ticker Report
10/6/2025
-
PR Newswire
9/30/2025
-
Stocktwits News Feed
9/29/2025
-
GuruFocus
9/29/2025
-
GuruFocus
9/29/2025
-
The Fly
9/29/2025
-
PR Newswire
9/9/2025
-
Ticker Report
9/5/2025
-
GuruFocus
9/5/2025
-
GuruFocus
9/5/2025
-
PR Newswire
8/20/2025
-
GuruFocus
8/20/2025
-
GuruFocus
8/20/2025
-
TipRanks Financial Blog
8/20/2025
-
PR Newswire
8/18/2025
-
TipRanks Financial Blog
8/18/2025
-
The Fly
8/18/2025
-
PR Newswire
7/29/2025
-
Ticker Report
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, September 5, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Apr 6 and 10 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
972 3 541 3131
Address
21 Ha’arba’a Street
Tel Aviv, 6473921
Tel Aviv, 6473921
Country
Year Founded
Business Description
Sector
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of...
more